Sarma A, Kataki AC, Rai AK, Hazarika M, Roy PS, Kalita M, et al. Promoter Hypermethylation of ATG16L2, TFAP2A, EBF2, Calcitonin, ABL1 Kinase Domain T315I Mutation Association with Imatinib Therapy Resistance and Median Survival in CML Patients of North-East India. Asian Pac J Cancer Care [Internet]. 2023 Feb. 17 [cited 2026 May 29];8(1):35-42. Available from: http://www.waocp.com/journal/index.php/apjcc/article/view/967